Concourse Financial Group Securities, Inc. Htg Molecular Diagnostics, Inc Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022
BUY
$0.62 - $1.89 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$0.46 - $1.45 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$1.39 - $5.51 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$3.23 - $5.97 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$5.01 - $6.8 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$3.52 - $5.98 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$4.99 - $7.83 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021
BUY
$4.14 - $5.95 $0 - $0
0 New
0 $0

Others Institutions Holding HTGM

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About HTG MOLECULAR DIAGNOSTICS, INC

HTGM Quotes by TradingView
  • Ticker HTGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 11,048,100
  • Market Cap $3.76M
  • Description
  • HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-o...
More about HTGM
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email